Advagene Biopharma Co (ROCO:6709) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Advagene Biopharma Co's Free Cash Flow for the six months ended in Jun. 2023 was NT$-39.30 Mil. Advagene Biopharma Co's Revenue for the six months ended in Jun. 2023 was NT$0.00 Mil. Therefore, Advagene Biopharma Co's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Advagene Biopharma Co's current FCF Yield % is -6.17%.

The historical rank and industry rank for Advagene Biopharma Co's FCF Margin % or its related term are showing as below:

ROCO:6709's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -137.43
* Ranked among companies with meaningful FCF Margin % only.

Advagene Biopharma Co FCF Margin % Historical Data

The historical data trend for Advagene Biopharma Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co FCF Margin % Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Advagene Biopharma Co's FCF Margin %

For the Biotechnology subindustry, Advagene Biopharma Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's FCF Margin % falls into.

Advagene Biopharma Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Advagene Biopharma Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-77.697	/	0
	=	%

Advagene Biopharma Co's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-39.296	/	0
	=	%

Advagene Biopharma Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines